chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.0
Sex: M
Vaccine: VARCEL, VARCEL
Symptoms: Antibody test positive, Blood test abnormal, Exposure to communicable disease, Immunoglobulin therapy, Polymerase chain reaction
Clinical narrative: This literature marketed report from author (physician) refers to a 12 year old male patient with stage IIA Hodgkin disease. On an unknown date, the patient developed vesicular lesions on his trunk and left shoulder. He had been diagnosed with Hodgkin disease 3 months before the current episode. As for all new cancer patients, a history was obtained, which revealed that the patient was vaccinated with a single dose of VARIVAX (Merck) at age 1 and confirmed a positive varicella zoster virus (VZV)-IgG antibody titer of >0.90 on an unknown date, before administering chemotherapy or any blood products. Within 3 months, the patient had completed 4 cycles of chemotherapy, as well as radiation therapy. The patient's father, who was the sole caregiver, had contracted varicella 9 days before the patient's rash was evident. The father had no history of varicella of vaccination. The father was given a prescription for oral acyclovir after diagnosis. When the father's varicella diagnosis was reported to the patient's physician, the patient was given a single infusion of intravenous (IV) immunoglobulin (400 mg/kg), owing to the close exposure to a family member. Nevertheless on an unknown date, the patient presented with varicella 4 days later. Considering that VZV was transmissible for 2 days before the onset of rash, the incubation period between father and son was at least 11 days. The patient was admitted to the hospital and was given IV acyclovir (45 mg/kg/day). His lesions quickly crusted and he was discharged on oral acyclovir after completing a 5-day course of IV acyclovir. On day 8, however, the patient developed new vesicles on his trunk, and subsequently was readmitted and restarted on IV acyclovir. He was discharged with a prescription for oral valacyclovir (1000-mg tablet every 8 hours) for 1 month. On an unknown date, the event varicella was resolved. His symptoms resolved without a recurrence of varicella. A VZV-specific polymerase chain reaction amplification test performed on a peripheral blood sample obtained on day 8 was positive for open reading frame (ORF) 62 sequences resembling those found in wild-type VZV DNA and negative for those found in vaccine VZV DNA. The author assessed the event as related to VARIVAX (Merck). The author concluded that protection after varicella vaccination especially after a single varicella vaccination is not life long. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL, VARCEL
Symptoms: Rash vesicular, Scab, Skin lesion, Varicella post vaccine, Varicella virus test positive
Clinical narrative: This literature marketed report from author (physician) refers to a 12 year old male patient with stage IIA Hodgkin disease. On an unknown date, the patient developed vesicular lesions on his trunk and left shoulder. He had been diagnosed with Hodgkin disease 3 months before the current episode. As for all new cancer patients, a history was obtained, which revealed that the patient was vaccinated with a single dose of VARIVAX (Merck) at age 1 and confirmed a positive varicella zoster virus (VZV)-IgG antibody titer of >0.90 on an unknown date, before administering chemotherapy or any blood products. Within 3 months, the patient had completed 4 cycles of chemotherapy, as well as radiation therapy. The patient's father, who was the sole caregiver, had contracted varicella 9 days before the patient's rash was evident. The father had no history of varicella of vaccination. The father was given a prescription for oral acyclovir after diagnosis. When the father's varicella diagnosis was reported to the patient's physician, the patient was given a single infusion of intravenous (IV) immunoglobulin (400 mg/kg), owing to the close exposure to a family member. Nevertheless on an unknown date, the patient presented with varicella 4 days later. Considering that VZV was transmissible for 2 days before the onset of rash, the incubation period between father and son was at least 11 days. The patient was admitted to the hospital and was given IV acyclovir (45 mg/kg/day). His lesions quickly crusted and he was discharged on oral acyclovir after completing a 5-day course of IV acyclovir. On day 8, however, the patient developed new vesicles on his trunk, and subsequently was readmitted and restarted on IV acyclovir. He was discharged with a prescription for oral valacyclovir (1000-mg tablet every 8 hours) for 1 month. On an unknown date, the event varicella was resolved. His symptoms resolved without a recurrence of varicella. A VZV-specific polymerase chain reaction amplification test performed on a peripheral blood sample obtained on day 8 was positive for open reading frame (ORF) 62 sequences resembling those found in wild-type VZV DNA and negative for those found in vaccine VZV DNA. The author assessed the event as related to VARIVAX (Merck). The author concluded that protection after varicella vaccination especially after a single varicella vaccination is not life long. Additional information has been requested.
Age: 12.0
Sex: M
Vaccine: VARCEL, VARCEL
Symptoms: Antibody test positive, Exposure to communicable disease, Immunoglobulin therapy, Polymerase chain reaction, Rash vesicular
Clinical narrative: This literature marketed report was received from author (physician) refers to a 12 year old male patient with stage IIA Hodgkin disease. On an unknown date, the patient developed vesicular lesions on his trunk and left shoulder. He had been diagnosed with Hodgkin disease 3 months before the current episode. As for all new cancer patients, a history was obtained, which revealed that the patient was vaccinated with a single dose of VARIVAX (Merck) (manufacturer unknown) at age 1 and confirmed a positive Varicella zoster virus (VZV)-IgG antibody titer of >0.90 on an unknown date, before administering chemotherapy or any blood products. Within 3 months, the patient had completed 4 cycles of chemotherapy, as well as radiation therapy. The patient's father, who was the sole caregiver, had contracted varicella 9 days before the patient's rash was evident. The father had no history of varicella or vaccination. The father was given a prescription for oral acyclovir after diagnosis. When the father's varicella diagnosis was reported to the patient's physician, the patient was given a single infusion of intravenous (IV) immunoglobulin (400 mg/kg), owing to the close exposure to a family member. Nevertheless on an unknown date, the patient presented with varicella 4 days later. Considering that VZV was transmissible for 2 days before the onset of rash, the incubation period between father and son was at least 11 days. The patient was admitted to the hospital and was given IV acyclovir (45 mg/kg/ day). His lesions quickly crusted and he was discharged on oral acyclovir after completing a 5-day course of IV acyclovir. On day 8, however, the patient developed new vesicles on his trunk, and subsequently was readmitted and restarted on IV acyclovir. He was discharged with a prescription for oral valacyclovir (1000-mg tablet every 8 hours) for 1 month. On an unknown date, the event varicella was resolved. His symptoms resolved without a recurrence of varicella. A VZV-specific polymerase chain reaction amplification test performed on a peripheral blood sample obtained on day 8 was positive for open reading frame (ORF) 62 sequences resembling those found in wild-type VZV DNA and negative for those found in vaccine VZV DNA. The author assessed the event as related to VARIVAX (Merck) (manufacturer unknown). The author concluded that protection after varicella vaccination especially after a single varicella vaccination is not life long. Additional information has been requested.
Age: 12.0
Sex: M
Vaccine: VARCEL, VARCEL
Symptoms: Scab, Varicella, Varicella virus test positive
Clinical narrative: This literature marketed report was received from author (physician) refers to a 12 year old male patient with stage IIA Hodgkin disease. On an unknown date, the patient developed vesicular lesions on his trunk and left shoulder. He had been diagnosed with Hodgkin disease 3 months before the current episode. As for all new cancer patients, a history was obtained, which revealed that the patient was vaccinated with a single dose of VARIVAX (Merck) (manufacturer unknown) at age 1 and confirmed a positive Varicella zoster virus (VZV)-IgG antibody titer of >0.90 on an unknown date, before administering chemotherapy or any blood products. Within 3 months, the patient had completed 4 cycles of chemotherapy, as well as radiation therapy. The patient's father, who was the sole caregiver, had contracted varicella 9 days before the patient's rash was evident. The father had no history of varicella or vaccination. The father was given a prescription for oral acyclovir after diagnosis. When the father's varicella diagnosis was reported to the patient's physician, the patient was given a single infusion of intravenous (IV) immunoglobulin (400 mg/kg), owing to the close exposure to a family member. Nevertheless on an unknown date, the patient presented with varicella 4 days later. Considering that VZV was transmissible for 2 days before the onset of rash, the incubation period between father and son was at least 11 days. The patient was admitted to the hospital and was given IV acyclovir (45 mg/kg/ day). His lesions quickly crusted and he was discharged on oral acyclovir after completing a 5-day course of IV acyclovir. On day 8, however, the patient developed new vesicles on his trunk, and subsequently was readmitted and restarted on IV acyclovir. He was discharged with a prescription for oral valacyclovir (1000-mg tablet every 8 hours) for 1 month. On an unknown date, the event varicella was resolved. His symptoms resolved without a recurrence of varicella. A VZV-specific polymerase chain reaction amplification test performed on a peripheral blood sample obtained on day 8 was positive for open reading frame (ORF) 62 sequences resembling those found in wild-type VZV DNA and negative for those found in vaccine VZV DNA. The author assessed the event as related to VARIVAX (Merck) (manufacturer unknown). The author concluded that protection after varicella vaccination especially after a single varicella vaccination is not life long. Additional information has been requested.
Age: 12.0
Sex: M
Vaccine: VARCEL, VARCEL
Symptoms: Antibody test positive, Blood test abnormal, Exposure to communicable disease, Immunoglobulin therapy, Polymerase chain reaction
Clinical narrative: This literature marketed report was received from author (physician) refers to a 12 year old male patient with stage IIA Hodgkin disease. On an unknown date, the patient developed vesicular lesions on his trunk and left shoulder. He had been diagnosed with Hodgkin disease 3 months before the current episode. As for all new cancer patients, a history was obtained, which revealed that the patient was vaccinated with a single dose of VARIVAX (Merck) (manufacturer unknown) at age 1 and confirmed a positive Varicella zoster virus (VZV)-IgG antibody titer of >0.90 on an unknown date, before administering chemotherapy or any blood products. Within 3 months, the patient had completed 4 cycles of chemotherapy, as well as radiation therapy. The patient's father, who was the sole caregiver, had contracted varicella 9 days before the patient's rash was evident. The father had no history of varicella or vaccination. The father was given a prescription for oral acyclovir after diagnosis. When the father's varicella diagnosis was reported to the patient's physician, the patient was given a single infusion of intravenous (IV) immunoglobulin (400 mg/kg), owing to the close exposure to a family member. Nevertheless on an unknown date, the patient presented with varicella 4 days later. Considering that VZV was transmissible for 2 days before the onset of rash, the incubation period between father and son was at least 11 days. The patient was admitted to the hospital and was given IV acyclovir (45 mg/kg/ day). His lesions quickly crusted and he was discharged on oral acyclovir after completing a 5-day course of IV acyclovir. On day 8, however, the patient developed new vesicles on his trunk, and subsequently was readmitted and restarted on IV acyclovir. He was discharged with a prescription for oral valacyclovir (1000-mg tablet every 8 hours) for 1 month. On an unknown date, the event varicella was resolved. His symptoms resolved without a recurrence of varicella. A VZV-specific polymerase chain reaction amplification test performed on a peripheral blood sample obtained on day 8 was positive for open reading frame (ORF) 62 sequences resembling those found in wild-type VZV DNA and negative for those found in vaccine VZV DNA. The author assessed the event as related to VARIVAX (Merck) (manufacturer unknown). The author concluded that protection after varicella vaccination especially after a single varicella vaccination is not life long. Additional information has been requested.
Age: 12.0
Sex: M
Vaccine: VARCEL, VARCEL
Symptoms: Rash vesicular, Scab, Skin lesion, Varicella post vaccine, Varicella virus test positive
Clinical narrative: This literature marketed report was received from author (physician) refers to a 12 year old male patient with stage IIA Hodgkin disease. On an unknown date, the patient developed vesicular lesions on his trunk and left shoulder. He had been diagnosed with Hodgkin disease 3 months before the current episode. As for all new cancer patients, a history was obtained, which revealed that the patient was vaccinated with a single dose of VARIVAX (Merck) (manufacturer unknown) at age 1 and confirmed a positive Varicella zoster virus (VZV)-IgG antibody titer of >0.90 on an unknown date, before administering chemotherapy or any blood products. Within 3 months, the patient had completed 4 cycles of chemotherapy, as well as radiation therapy. The patient's father, who was the sole caregiver, had contracted varicella 9 days before the patient's rash was evident. The father had no history of varicella or vaccination. The father was given a prescription for oral acyclovir after diagnosis. When the father's varicella diagnosis was reported to the patient's physician, the patient was given a single infusion of intravenous (IV) immunoglobulin (400 mg/kg), owing to the close exposure to a family member. Nevertheless on an unknown date, the patient presented with varicella 4 days later. Considering that VZV was transmissible for 2 days before the onset of rash, the incubation period between father and son was at least 11 days. The patient was admitted to the hospital and was given IV acyclovir (45 mg/kg/ day). His lesions quickly crusted and he was discharged on oral acyclovir after completing a 5-day course of IV acyclovir. On day 8, however, the patient developed new vesicles on his trunk, and subsequently was readmitted and restarted on IV acyclovir. He was discharged with a prescription for oral valacyclovir (1000-mg tablet every 8 hours) for 1 month. On an unknown date, the event varicella was resolved. His symptoms resolved without a recurrence of varicella. A VZV-specific polymerase chain reaction amplification test performed on a peripheral blood sample obtained on day 8 was positive for open reading frame (ORF) 62 sequences resembling those found in wild-type VZV DNA and negative for those found in vaccine VZV DNA. The author assessed the event as related to VARIVAX (Merck) (manufacturer unknown). The author concluded that protection after varicella vaccination especially after a single varicella vaccination is not life long. Additional information has been requested.
Age: 68.0
Sex: M
Vaccine: FLU3
Symptoms: Electromyogram, Injection site reaction, Laboratory test, Monoparesis, Muscular weakness
Clinical narrative: Three days after flu shot on 9/3, pain in neck and shoulder. Approximately 7-8 days after shot, weakness in left arm (site of shot) and left hand. Admitted at hospital on 9/15 for 3 days resulting in diagnosis of peripheral neuropathy - paresis left upper extremity. Physical therapy began 9/24 outpatient.
Age: 68.0
Sex: M
Vaccine: FLU3
Symptoms: Musculoskeletal pain, Neck pain, Neuropathy peripheral
Clinical narrative: Three days after flu shot on 9/3, pain in neck and shoulder. Approximately 7-8 days after shot, weakness in left arm (site of shot) and left hand. Admitted at hospital on 9/15 for 3 days resulting in diagnosis of peripheral neuropathy - paresis left upper extremity. Physical therapy began 9/24 outpatient.
Age: 6.0
Sex: F
Vaccine: DTAP
Symptoms: Blood test, Dyspnoea, Erythema, Feeling abnormal, Injection site erythema
Clinical narrative: Fever, very sore, red, hot, swollen entire upper arm and under armpit into chest, distinct red lines running down torso under right arm, feeling ill, vomiting, difficulty breathing. Came home from getting vaccine complaining of pain approx. 3 hrs. later, got fever (100.8) and increasing pain with swelling starting about 8 om. Went to bed with ibuprofen for pain/fever, awoke 1 am in pain, more ibuprofen. Awoke next morning (7a) in pain, (gave BENADRYL and ibuprofen) very swollen and large red area around site. Visit to dr - gave more BENADRYL circled site - advised to call if extends beyond border or pain worsens. About 8 p gave more BENADRYL, swelling getting worse, redness intensifying, complaining of extreme pain. Gave ibuprofen and BENADRYL every 6 hrs. Awoke in morning vomiting complaining of more pain, redness traveling up/down arm into chest, very swollen, saying she felt terrible. Was instructed to go to ER - admitted, breathing difficulty/wheezing.
Age: 6.0
Sex: F
Vaccine: DTAP
Symptoms: Injection site pain, Injection site swelling, Injection site warmth, Local swelling, Malaise
Clinical narrative: Fever, very sore, red, hot, swollen entire upper arm and under armpit into chest, distinct red lines running down torso under right arm, feeling ill, vomiting, difficulty breathing. Came home from getting vaccine complaining of pain approx. 3 hrs. later, got fever (100.8) and increasing pain with swelling starting about 8 om. Went to bed with ibuprofen for pain/fever, awoke 1 am in pain, more ibuprofen. Awoke next morning (7a) in pain, (gave BENADRYL and ibuprofen) very swollen and large red area around site. Visit to dr - gave more BENADRYL circled site - advised to call if extends beyond border or pain worsens. About 8 p gave more BENADRYL, swelling getting worse, redness intensifying, complaining of extreme pain. Gave ibuprofen and BENADRYL every 6 hrs. Awoke in morning vomiting complaining of more pain, redness traveling up/down arm into chest, very swollen, saying she felt terrible. Was instructed to go to ER - admitted, breathing difficulty/wheezing.
Age: 6.0
Sex: F
Vaccine: DTAP
Symptoms: Pyrexia, Skin warm, Vomiting, Wheezing
Clinical narrative: Fever, very sore, red, hot, swollen entire upper arm and under armpit into chest, distinct red lines running down torso under right arm, feeling ill, vomiting, difficulty breathing. Came home from getting vaccine complaining of pain approx. 3 hrs. later, got fever (100.8) and increasing pain with swelling starting about 8 om. Went to bed with ibuprofen for pain/fever, awoke 1 am in pain, more ibuprofen. Awoke next morning (7a) in pain, (gave BENADRYL and ibuprofen) very swollen and large red area around site. Visit to dr - gave more BENADRYL circled site - advised to call if extends beyond border or pain worsens. About 8 p gave more BENADRYL, swelling getting worse, redness intensifying, complaining of extreme pain. Gave ibuprofen and BENADRYL every 6 hrs. Awoke in morning vomiting complaining of more pain, redness traveling up/down arm into chest, very swollen, saying she felt terrible. Was instructed to go to ER - admitted, breathing difficulty/wheezing.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Mobility decreased, Pain in extremity, Palpitations, Pyrexia
Clinical narrative: Case number PHEH2013US020780, is an initial spontaneous report received from the health care professional on 04 Oct 2013. This report refers to a 65-year-old female patient. Her medical history and concomitant medications was not reported. She was vaccinated with FLUVIRIN (batch number: not reported) on 01 Oct 2013. After the vaccination, she experienced a lot of pain and she couldn't lift her arm and arm was red, on unknown date. She also broke out in rash, was feverish and felt like her heart was racing. She felt better on 04 Oct 2013. The event outcome was condition improving as of 04 Oct 2013. The seriousness and causality of the events were not reported. No additional information was available.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Rash
Clinical narrative: Case number PHEH2013US020780, is an initial spontaneous report received from the health care professional on 04 Oct 2013. This report refers to a 65-year-old female patient. Her medical history and concomitant medications was not reported. She was vaccinated with FLUVIRIN (batch number: not reported) on 01 Oct 2013. After the vaccination, she experienced a lot of pain and she couldn't lift her arm and arm was red, on unknown date. She also broke out in rash, was feverish and felt like her heart was racing. She felt better on 04 Oct 2013. The event outcome was condition improving as of 04 Oct 2013. The seriousness and causality of the events were not reported. No additional information was available.
Sex: M
Vaccine: FLUX
Symptoms: Contusion, Loss of consciousness, Road traffic accident
Clinical narrative: Case number PHEH2013US021151 is an initial spontaneous report from the consumer (patient's friend) received on 08 Oct 2013. This report refers to a male patient. The patient's medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 07 Oct 2013. On the same date, while returning from the clinic the patient suddenly passed out while driving. It was reported that he went off the road and his car flipped over. The patient had bumps and bruises, but he was fine and refused to visit the emergency room. The outcome of the events was reported as recovered. The events were reported as serious by the reporter. The causality of the events was not reported.
Age: 39.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Dyspnoea, Eye irritation, Nausea, Throat tightness, Vomiting
Clinical narrative: Pt received FLUZONE vaccination at health dept on 10/8/13 at 3:00 pm. Upon arriving home pt. stated she began to experience SOB, eye irritation, N/V, and throat tightening. Pt. took 50 mg BENADRYL. Pt. husband drove her to medical center. Arrived at hospital 5:30 pm. Pt. was examined and treated with famotidine 20 mg, methylprednisolone sod. succ. 125 mg. NS bolus infusion and ondansetron 4 mg for allergic reaction and pt released.
Age: 39.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Dyspnoea, Eye irritation, Hypersensitivity, Nausea, Throat tightness
Clinical narrative: Pt received FLUZONE vaccination at health dept on 10/8/13 at 3:00 pm. Upon arriving home pt. stated she began to experience SOB, eye irritation, N/V, and throat tightening. Pt. took 50 mg BENADRYL. Pt. husband drove her to medical center. Arrived at hospital 5:30 pm. Pt. was examined and treated with famotidine 20 mg, methylprednisolone sod. succ. 125 mg. NS bolus infusion and ondansetron 4 mg for allergic reaction and pt released.
Age: 39.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Vomiting
Clinical narrative: Pt received FLUZONE vaccination at health dept on 10/8/13 at 3:00 pm. Upon arriving home pt. stated she began to experience SOB, eye irritation, N/V, and throat tightening. Pt. took 50 mg BENADRYL. Pt. husband drove her to medical center. Arrived at hospital 5:30 pm. Pt. was examined and treated with famotidine 20 mg, methylprednisolone sod. succ. 125 mg. NS bolus infusion and ondansetron 4 mg for allergic reaction and pt released.
Age: 39.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Dyspnoea, Eye irritation, Nausea, Throat tightness, Vomiting
Clinical narrative: Pt. received FLUZONE vaccination at Co. Health Dept. on 10/8/13 at 3:00pm. Upon arriving home pt. stated she began to experience SOB, eye irritation, N/V, and throat tightening. Pt. took 50mg BENADRYL. Pt. husband drove her to Medical Center. Arrived at hospital 5:30pm. Pt. was examined and treated with famotidine 20mg, methylprednisolone sod. succ. 125mg, NS bolus infusion and ondansetron 4mg for allergic reaction and pt. released.
Age: 39.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Dyspnoea, Eye irritation, Hypersensitivity, Nausea, Throat tightness
Clinical narrative: Pt. received FLUZONE vaccination at Co. Health Dept. on 10/8/13 at 3:00pm. Upon arriving home pt. stated she began to experience SOB, eye irritation, N/V, and throat tightening. Pt. took 50mg BENADRYL. Pt. husband drove her to Medical Center. Arrived at hospital 5:30pm. Pt. was examined and treated with famotidine 20mg, methylprednisolone sod. succ. 125mg, NS bolus infusion and ondansetron 4mg for allergic reaction and pt. released.
Age: 39.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Vomiting
Clinical narrative: Pt. received FLUZONE vaccination at Co. Health Dept. on 10/8/13 at 3:00pm. Upon arriving home pt. stated she began to experience SOB, eye irritation, N/V, and throat tightening. Pt. took 50mg BENADRYL. Pt. husband drove her to Medical Center. Arrived at hospital 5:30pm. Pt. was examined and treated with famotidine 20mg, methylprednisolone sod. succ. 125mg, NS bolus infusion and ondansetron 4mg for allergic reaction and pt. released.
Age: 32.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: Fatigue, muscle aches, headache, fever, chills.
Age: 2.0
Sex: M
Vaccine: FLU4
Symptoms: Chest X-ray normal, Febrile convulsion, Haematocrit normal, Haemoglobin normal, Lymphocyte percentage decreased
Clinical narrative: 60 Second febrile seizure, went to ER by EMS, no treatment done besides Tylenol.
Age: 2.0
Sex: M
Vaccine: FLU4
Symptoms: Neutrophil percentage, Platelet count normal, White blood cell count normal
Clinical narrative: 60 Second febrile seizure, went to ER by EMS, no treatment done besides Tylenol.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Allergy test, Cardiac stress test, Catheterisation cardiac, Cough, Echocardiogram
Clinical narrative: Raspy tickling throat, coughing fever, tiredness, and body aches. Approximately 20 days later fatigue and body numbness appear on side of hands. A few days later legs starting getting weaker walking became more difficult.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Electrocardiogram, Fatigue, Gait disturbance, Guillain-Barre syndrome, Hypoaesthesia
Clinical narrative: Raspy tickling throat, coughing fever, tiredness, and body aches. Approximately 20 days later fatigue and body numbness appear on side of hands. A few days later legs starting getting weaker walking became more difficult.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Muscular weakness, Nerve conduction studies, Nuclear magnetic resonance imaging brain, Pain, Pyrexia
Clinical narrative: Raspy tickling throat, coughing fever, tiredness, and body aches. Approximately 20 days later fatigue and body numbness appear on side of hands. A few days later legs starting getting weaker walking became more difficult.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Throat irritation
Clinical narrative: Raspy tickling throat, coughing fever, tiredness, and body aches. Approximately 20 days later fatigue and body numbness appear on side of hands. A few days later legs starting getting weaker walking became more difficult.
Age: 50.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Mobility decreased, Upper extremity mass
Clinical narrative: Not able to life arm, hot swollen lump in arm, turned to red lumps.
Age: 69.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: Severe pain at injection site went to ER with severe pain, swelling at injection site and fever.
Age: 14.0
Sex: F
Vaccine: FLUX, HPV4, FLUX, HPV4
Symptoms: Balance disorder, Chest pain, Headache, Influenza like illness, Palpitations
Clinical narrative: 9/11: rash x 2 days, flu like symptoms x 1 week. 9/19: chest pain, palpitations. Improving. 9/22: headache, dysequilibrium. Persistent. No prior similar symptoms.
Age: 14.0
Sex: F
Vaccine: FLUX, HPV4, FLUX, HPV4
Symptoms: Rash
Clinical narrative: 9/11: rash x 2 days, flu like symptoms x 1 week. 9/19: chest pain, palpitations. Improving. 9/22: headache, dysequilibrium. Persistent. No prior similar symptoms.
Age: 14.0
Sex: F
Vaccine: FLUX, HPV4, FLUX, HPV4
Symptoms: Aphasia, Cerebrovascular accident, Chest X-ray, Chest pain, Confusional state
Clinical narrative: 9/11: rash x 2 days, flu like symptoms x 1 week. 9/19: chest pain, palpitations. Improving. 9/22: headache, dysequilibrium. Persistent. No prior similar symptoms.
Age: 14.0
Sex: F
Vaccine: FLUX, HPV4, FLUX, HPV4
Symptoms: Dizziness, Dyskinesia, Electrocardiogram, Headache, Influenza like illness
Clinical narrative: 9/11: rash x 2 days, flu like symptoms x 1 week. 9/19: chest pain, palpitations. Improving. 9/22: headache, dysequilibrium. Persistent. No prior similar symptoms.
Age: 14.0
Sex: F
Vaccine: FLUX, HPV4, FLUX, HPV4
Symptoms: Nuclear magnetic resonance imaging, Pain, Pain in extremity, Postural orthostatic tachycardia syndrome, Rash
Clinical narrative: 9/11: rash x 2 days, flu like symptoms x 1 week. 9/19: chest pain, palpitations. Improving. 9/22: headache, dysequilibrium. Persistent. No prior similar symptoms.
Age: 14.0
Sex: F
Vaccine: FLUX, HPV4, FLUX, HPV4
Symptoms: Tachycardia
Clinical narrative: 9/11: rash x 2 days, flu like symptoms x 1 week. 9/19: chest pain, palpitations. Improving. 9/22: headache, dysequilibrium. Persistent. No prior similar symptoms.
Age: 43.0
Sex: F
Vaccine: FLUX
Symptoms: Eye swelling, Ocular hyperaemia
Clinical narrative: I have never received a flu shot before. My eyes became blood shot approx. 9:30 pm. Morning of 10/11/13 eyes almost swollen shut and still blood shot. They do not itch or burn.
Age: 0.46
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13
Symptoms: Rash generalised
Clinical narrative: At next visit to clinic mother states rash appeared "all over" boy approximately 24 hours after vaccines were given on 4/29/13.
Age: 25.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site inflammation, Injection site pain, Injection site swelling, Pyrexia, Vomiting
Clinical narrative: Pt was treated at Medical Center for inflammation and pain at the injection site, swelling of the left arm distal to injection site, fever and vomiting.
Age: 63.0
Sex: F
Vaccine: FLU3
Symptoms: Eye swelling, Muscle tightness, Paraesthesia oral, Throat tightness
Clinical narrative: Patient complained of swollen eyes, throat tightening, tongue tingling, jaw tightening that persisted for a good 2 hours even after taking a Benadryl tablet.
Age: 42.0
Sex: M
Vaccine: FLUX
Symptoms: Arthralgia, Chills, Malaise, Pain, Pyrexia
Clinical narrative: Fever, Chills, Body Aches, Joint Pain, Malaise lasting approx 6 hours.
Age: 58.0
Sex: F
Vaccine: FLU4
Symptoms: Fatigue, Headache, Pruritus, Pyrexia, Rash
Clinical narrative: Patient complained of severe fatigue, fever of 100.9 to 101.9 most elevated in evenings, lasted 2.5 days. Patient stated she also had a nagging headache and rash, itchy to back and shoulder areas. Symptoms resolved on 3rd day.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, FLUX, MMR, VARCEL
Symptoms: Eyelid oedema, Swelling face
Clinical narrative: Swollen eyelids and forehead. No respiratory symptoms.
Age: 1.75
Sex: F
Vaccine: DTAP
Symptoms: Erythema, Induration, Tenderness
Clinical narrative: Slight redness, golf ball induration distal to injection site, tenderness.
Age: 42.0
Sex: F
Vaccine: FLUN4
Symptoms: Asthenia, Dizziness, Nausea
Clinical narrative: Dizziness, nausea, weakness.
Age: 41.0
Sex: F
Vaccine: FLU3
Symptoms: Axillary pain, Chest pain, Injection site pain, Oedema peripheral, Pain in extremity
Clinical narrative: Pain in left upper arm radiating down length of left arm.  The following day had pain and swelling over left lateral chest and underarm.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Chills, Discomfort, Injection site erythema, Local swelling
Clinical narrative: Chilling, increased redness at injection site, swelling and general feeling of beginning discomfort.  This increased until my arm was swollen about two inches from my wrist and the redness increased to bright/angry red and then burgundy.  The discoloration circled my arm and swelling continued from Wednesday pm until Tuesday am when it began to dissipate.  Without constant ice the swelling was very uncomfortable and began itching Sunday. Additionally I was extremely weak to the point of feeling as though I would fall whenever I tried to ambulate around the house. My throat felt slightly constricted for about eight hours but did not feel as though breathing was compromised.  Friday morning I felt as though I would vomit and experienced dry heaves.   The MD and Pharmacist indicated ice, ibuprofen and time is all that could be done to assist.  That treatment and almost around the clock sleeping Friday, Saturday and much of Sunday was the treatment.  Today, Friday October 11 my arm continues to be slightly swollen but much diminished and redness is slight at the injection site.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Nausea, Pruritus, Retching, Skin discolouration, Swelling
Clinical narrative: Chilling, increased redness at injection site, swelling and general feeling of beginning discomfort.  This increased until my arm was swollen about two inches from my wrist and the redness increased to bright/angry red and then burgundy.  The discoloration circled my arm and swelling continued from Wednesday pm until Tuesday am when it began to dissipate.  Without constant ice the swelling was very uncomfortable and began itching Sunday. Additionally I was extremely weak to the point of feeling as though I would fall whenever I tried to ambulate around the house. My throat felt slightly constricted for about eight hours but did not feel as though breathing was compromised.  Friday morning I felt as though I would vomit and experienced dry heaves.   The MD and Pharmacist indicated ice, ibuprofen and time is all that could be done to assist.  That treatment and almost around the clock sleeping Friday, Saturday and much of Sunday was the treatment.  Today, Friday October 11 my arm continues to be slightly swollen but much diminished and redness is slight at the injection site.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Throat tightness
Clinical narrative: Chilling, increased redness at injection site, swelling and general feeling of beginning discomfort.  This increased until my arm was swollen about two inches from my wrist and the redness increased to bright/angry red and then burgundy.  The discoloration circled my arm and swelling continued from Wednesday pm until Tuesday am when it began to dissipate.  Without constant ice the swelling was very uncomfortable and began itching Sunday. Additionally I was extremely weak to the point of feeling as though I would fall whenever I tried to ambulate around the house. My throat felt slightly constricted for about eight hours but did not feel as though breathing was compromised.  Friday morning I felt as though I would vomit and experienced dry heaves.   The MD and Pharmacist indicated ice, ibuprofen and time is all that could be done to assist.  That treatment and almost around the clock sleeping Friday, Saturday and much of Sunday was the treatment.  Today, Friday October 11 my arm continues to be slightly swollen but much diminished and redness is slight at the injection site.
Age: 17.0
Sex: M
Vaccine: FLUX
Symptoms: Activities of daily living impaired, Arthralgia, Chest X-ray normal, Dizziness, Fatigue
Clinical narrative: Fever, lightheaded, abnormal breathing, arthalgias, tingling of hands/feet, malaise, loss of feeling in legs. Acute onset. ER visit.
Age: 17.0
Sex: M
Vaccine: FLUX
Symptoms: Hypoaesthesia, Influenza virus test negative, Laboratory test normal, Malaise, Paraesthesia
Clinical narrative: Fever, lightheaded, abnormal breathing, arthalgias, tingling of hands/feet, malaise, loss of feeling in legs. Acute onset. ER visit.
Age: 17.0
Sex: M
Vaccine: FLUX
Symptoms: Pyrexia, Respiration abnormal, Urine analysis normal, Viral infection
Clinical narrative: Fever, lightheaded, abnormal breathing, arthalgias, tingling of hands/feet, malaise, loss of feeling in legs. Acute onset. ER visit.
Age: 37.0
Sex: M
Vaccine: TTOX
Symptoms: Respiratory tract congestion
Clinical narrative: Approx. 3 hours after receiving tetanus shot donor states became congested and it lasted until he went to bed and the next morning got up feeling fine.
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Injection site pain, Injection site swelling, Irritability
Clinical narrative: Swelling of right thigh, tenderness and pain. Very fussy infant.
Age: 62.0
Sex: F
Vaccine: FLUX
Symptoms: Asthenia, Body temperature, Chills, Headache, Joint swelling
Clinical narrative: Feeling weak, and chilled, followed by temperature, later rash, small itchy bumps on hands and feet, swollen joints, weak muscles, and headaches.
Age: 62.0
Sex: F
Vaccine: FLUX
Symptoms: Muscular weakness, Rash, Rash pruritic
Clinical narrative: Feeling weak, and chilled, followed by temperature, later rash, small itchy bumps on hands and feet, swollen joints, weak muscles, and headaches.
Age: 26.0
Sex: F
Vaccine: FLU3
Symptoms: Feeling abnormal, Injection site pain, Musculoskeletal pain, Pruritus, Rash
Clinical narrative: Pain at injection site, radiating up into shoulder accompanied with a "hazy" feeling.  These symptoms cleared by 03:00 PM. That evening started experiencing itching and a rash in the upper chest area.  These symptoms persist and although better still exist.
Age: 19.0
Sex: M
Vaccine: FLU3
Symptoms: Accidental exposure to product, HIV test, Injury associated with device
Clinical narrative: PT flinched causing needle to inject provider.
Age: 42.0
Sex: M
Vaccine: FLUN4
Symptoms: Paraesthesia, Pruritus
Clinical narrative: 42 year old with a suspected adverse reaction to Flumist.  He was vaccinated on 24 Sept 2013.  He has had the Flumist at least 5 other times in the past with no issues.  He states that the following mid-afternoon (about 24 hours after the mist) he noticed the development of a tingling sensation in his arms/legs/feet/face that started.  This lasted about 1 hour and resolved.  This tingling sensation occurs about 3-4 times throughout the day.  He denies any fevers/arthralgias/muscle aches/pains.  He states that he feels like this causes his skin to itch during these events as well.  He has had these sympoms for over 14 days and they have roughly stayed the same.  He has not tried any medicaitons to fix this.  He has never had this type of reaction ever in the past. He denies any shortness of breath/angioedema/hives/GI symptoms/light-headedness/dizziness.
Age: 12.0
Sex: M
Vaccine: FLU3
Symptoms: Back pain, Chest pain, Injection site bruising, Injection site swelling, Nausea
Clinical narrative: Pt felt nauseated and achy in back, arms and chest. Also some pain at vaccine site. Tiny bump and sm amt bruising at site sl under 1 cm. No treatment. Pt also ate chicken salad sandwich last night with a caffeine slushy.
Age: 12.0
Sex: M
Vaccine: FLU3
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: Pt felt nauseated and achy in back, arms and chest. Also some pain at vaccine site. Tiny bump and sm amt bruising at site sl under 1 cm. No treatment. Pt also ate chicken salad sandwich last night with a caffeine slushy.
Age: 35.0
Sex: F
Vaccine: FLU3
Symptoms: Cough, Dry throat, Dyspnoea, Eye pruritus, Fatigue
Clinical narrative: Extreme fatigue, sweating, swollen glands, shortness of breath 15 minutes after getting the shot. Took Claritin, but it didn't help. Coughing and wheezing, dry throat, itching eyes by 2:30 PM. Took 50 mg of Benadryl. That helped some. Took Benadryl at bedtime. The site of intradermal shot was red, hard, swollen, and painful down to her elbow. Most symptoms lessened by the next morning. on 10/11/13, still reports shortness of breath, cough, some wheezing, and glands swollen. Has had other vaccines in the past, TB, MMR, and Hep B, but did not have any reactions to those injections.
Age: 35.0
Sex: F
Vaccine: FLU3
Symptoms: Hyperhidrosis, Injection site erythema, Injection site induration, Injection site pain, Injection site swelling
Clinical narrative: Extreme fatigue, sweating, swollen glands, shortness of breath 15 minutes after getting the shot. Took Claritin, but it didn't help. Coughing and wheezing, dry throat, itching eyes by 2:30 PM. Took 50 mg of Benadryl. That helped some. Took Benadryl at bedtime. The site of intradermal shot was red, hard, swollen, and painful down to her elbow. Most symptoms lessened by the next morning. on 10/11/13, still reports shortness of breath, cough, some wheezing, and glands swollen. Has had other vaccines in the past, TB, MMR, and Hep B, but did not have any reactions to those injections.
Age: 35.0
Sex: F
Vaccine: FLU3
Symptoms: Lymphadenopathy, Wheezing
Clinical narrative: Extreme fatigue, sweating, swollen glands, shortness of breath 15 minutes after getting the shot. Took Claritin, but it didn't help. Coughing and wheezing, dry throat, itching eyes by 2:30 PM. Took 50 mg of Benadryl. That helped some. Took Benadryl at bedtime. The site of intradermal shot was red, hard, swollen, and painful down to her elbow. Most symptoms lessened by the next morning. on 10/11/13, still reports shortness of breath, cough, some wheezing, and glands swollen. Has had other vaccines in the past, TB, MMR, and Hep B, but did not have any reactions to those injections.
Age: 70.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site bruising, Injection site erythema, Injection site swelling, Injection site warmth, Malaise
Clinical narrative: Pt reports fever two degrees above normal as well as general myalgia and malaise. At site of inject pt has a bruise approximately the size of a quarter surrounded by a raised, warm red area approximately 5 inches in diameter. Pt reports no pain or discomfort at injection site. Red area is raised approximately 2-3 mm above the surrounding area.
Age: 70.0
Sex: F
Vaccine: FLU3
Symptoms: Myalgia, Pyrexia
Clinical narrative: Pt reports fever two degrees above normal as well as general myalgia and malaise. At site of inject pt has a bruise approximately the size of a quarter surrounded by a raised, warm red area approximately 5 inches in diameter. Pt reports no pain or discomfort at injection site. Red area is raised approximately 2-3 mm above the surrounding area.
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site discomfort, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Patient reports receiving an Influenza vaccine yesterday. Area where injection was placed is swollen to about the size of an egg and seems to be continuing to swell. Patient also reports area is warm to the touch and painful. She denies a fever but has been taking IBU to help with the discomfort. Recommended patient place cold packs to area--if no relief today patient will go to Urgent Care for eval.
Age: 44.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Pruritus generalised, Rash macular
Clinical narrative: Emp states received Flu vaccine approx 1045 and slowly noticed she was itchy. At 2:30 emp was itchy to face, neck, arms and head. Neck and upper arms became reddened and blotchy. No respiratory symptoms. Benadryl 25 mg po given at 3:40 pm rechecked emp at 4:46 symptoms resolving itch was almost gone and redened areas disipated to pink.
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Abasia, Arthralgia, Joint swelling, Laboratory test, Mobility decreased
Clinical narrative: Severe joint pain and swelling in all her joints. Unable to walk or bend. On December 24, 2010, Dr. at hospital diagnosed her with psoriatic arthritis. Prescribed Prednisone and Methotrexate and Lucavorin.
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Psoriatic arthropathy
Clinical narrative: Severe joint pain and swelling in all her joints. Unable to walk or bend. On December 24, 2010, Dr. at hospital diagnosed her with psoriatic arthritis. Prescribed Prednisone and Methotrexate and Lucavorin.
Age: 72.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Dysphagia, Hypersensitivity, Pharyngeal oedema
Clinical narrative: Allergic reaction.  Swelling of throat, took Benadryl.  Swallowing got better.  Followed by chills.
Age: 64.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Induration, Local swelling, Malaise
Clinical narrative: Redness, swelling down bicep of arm hard swelling spot on bicep, patient not feeling well for several days.
Age: 64.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Erythema, Induration, Pain, Skin warm
Clinical narrative: Developed redness, soreness, hot to the touch, and hardened area.
Age: 8.0
Sex: M
Vaccine: FLU3
Symptoms: Electroencephalogram normal, Tremor
Clinical narrative: Pt woke next morning with body shaking uncontrollably for more than 1 hr. Pt sent to ER.
Age: 70.0
Sex: F
Vaccine: FLUC3
Symptoms: Hypoglycaemia
Clinical narrative: Hypoglycemia - 5 minutes post immunization.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Herpes zoster, Pain of skin, Rash
Clinical narrative: 11 Sept 2013 small bumps were just below my hair line on the right side. 14 Sept I had blisters on right side of head in scalp and ear. 14 Sept 2013 I went an Emergency Dept, the doctor said I had shingles, I told him I had the vaccine in 2007 and he said well you have shingles I was given Prescription. I still have a lot of pain in my scalp but the blisters healing.
Age: 19.0
Sex: M
Vaccine: SMALL
Symptoms: Blood creatine phosphokinase increased, Chest X-ray normal, Echocardiogram normal, Myocarditis, Troponin T normal
Clinical narrative: Infection Control Nurse emails NP on 27FEB12 reporting inpatient admit on 24FEB12 via ER to 4-South for suspect SPV associated myocarditis. Patient is 19 y/o who recv'd his primary SPV (LUE) on 13FEB12 and AVA#1, Hep A#2, Typhoid ViCPs (RUE) on 10FEB12.